Michael Gerard
General Counsel bij CABALETTA BIO, INC.
Vermogen: - $ op 31-03-2024
Profiel
Michael Gerard is currently the Secretary & General Counsel at Cabaletta Bio, Inc. He previously worked as an Associate General Counsel at Spark Therapeutics, Inc. from 2020 to 2021.
Mr. Gerard received his undergraduate degree from the University of Michigan and his graduate degree from Cornell Law School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CABALETTA BIO, INC.
-.--% | 01-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Michael Gerard
Bedrijven | Functie | Begin |
---|---|---|
CABALETTA BIO, INC. | General Counsel | 07-09-2021 |
Eerdere bekende functies van Michael Gerard
Bedrijven | Functie | Einde |
---|---|---|
SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2021 |
Opleiding van Michael Gerard
University of Michigan | Undergraduate Degree |
Cornell Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CABALETTA BIO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |